バイオディフェンスの市場規模、シェア、成長分析、タイプ別、用途別、地域別 - 産業予測、2024年～2031年

バイオディフェンスの世界市場規模は、2022年に152億2,000万米ドルと評価され、2023年の159億9,000万米ドルから2031年には236億7,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは5.03％で成長する見通しです。

世界のバイオディフェンス市場は、生物製剤による脅威の高まりと、効果的な準備・対応戦略の必要性の高まりによって、最近顕著な成長と変貌を遂げています。バイオディフェンスは、バイオテロ、パンデミック、その他の生物学的緊急事態に関連するリスクに対処するために設計された、広範な活動と技術を包含しています。この市場には、ワクチン、治療薬、検出・診断、防護具など様々な分野が含まれます。バイオディフェンスソリューションに対する需要の高まりは、生物学的攻撃や発生が壊滅的な影響を及ぼす可能性に対する意識の高まりを反映しており、世界各国の政府がバイオディフェンス機能に多額の投資を行うきっかけとなっています。ゲノム科学、合成生物学、データ解析などの技術の進歩は、革新的で洗練されたバイオディフェンス製品の開発を促進しています。また、政府、防衛機関、民間組織間のコラボレーションも、包括的なバイオディフェンス戦略と市場成長を促進しています。しかし、規制上の障害、研究開発コストの高さ、バイオディフェンスの脅威の複雑な性質といった課題は、大きなハードルとなっています。このような課題にもかかわらず、各国がバイオディフェンス対策の強化に優先順位をつけて投資しているため、市場は拡大を続けると予想されます。

目次

イントロダクション

• 調査の目的
• 定義
• 市場範囲

調査手法

• 情報調達
• 二次データソースと一次データソース
• 市場規模予測
• 市場の想定と制限

エグゼクティブサマリー

• 市場概要見通し
• 供給需要動向分析
• セグメント別機会分析

市場力学と見通し

• 市場力学
  • 促進要因
  • 機会
  • 抑制要因
  • 課題
• ポーターの分析

主な市場の考察

• 主な成功要因
• 競合の程度
• 主な投資機会
• 市場のエコシステム
• 規制情勢
• 特許分析
• パイプライン製品の分析
• PESTEL分析

バイオディフェンス市場：タイプ別

• 市場概要
• 炭疽菌
• 天然痘
• ボツリヌス中毒
• 放射線/核
• その他

バイオディフェンス市場：用途別

• 市場概要
• 病院と診療所
• 外来診療センター
• その他

バイオディフェンス市場規模：地域別

• 市場概要
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ（MEA）
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ地域

競合情勢

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場における最近の活動
• 主要企業の市場シェア（2023年）

主要企業プロファイル

• XOMA Corporation
• Altimmune Inc.
• Emergent Biosolutions Inc.
• Dynavax Technologies Corporation
• SIGA Technologies
• Elusys Therapeutics Inc.
• Ichor Medical Systems
• Dynport Vaccine Company
• Cleveland Biolabs
• Bavarian Nordic
• Ology Bioservices
• Alnylam Pharmaceuticals Inc.
• BioCryst Pharmaceuticals Inc.
• PharmAthene Inc.
• Profectus Biosciences Inc.
• NanoViricides Inc.
• Takeda Pharmaceutical Company Limited
• Sanofi Pasteur
• GlaxoSmithKline

Global Biodefense Market size was valued at USD 15.22 billion in 2022 and is poised to grow from USD 15.99 billion in 2023 to USD 23.67 billion by 2031, growing at a CAGR of 5.03% during the forecast period (2024-2031).

The global biodefense market has experienced notable growth and transformation recently, driven by escalating threats from biological agents and the increasing need for effective preparedness and response strategies. Biodefense encompasses a broad array of activities and technologies designed to address risks related to bioterrorism, pandemics, and other biological emergencies. This market includes various sectors such as vaccines, therapeutics, detection and diagnostics, and protective equipment. The rising demand for biodefense solutions reflects heightened awareness of the potentially devastating impacts of biological attacks and outbreaks, leading governments worldwide to invest heavily in biodefense capabilities. Technological advancements, including genomics, synthetic biology, and data analytics, are enhancing the development of innovative and sophisticated biodefense products. Collaborations between governments, defense agencies, and private sector organizations are also advancing comprehensive biodefense strategies and market growth. However, challenges such as regulatory obstacles, high R&D costs, and the complex nature of biodefense threats present significant hurdles. Despite these challenges, the market is expected to continue expanding as countries prioritize and invest in strengthening their biodefense measures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biodefense market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segmental Analysis

Global Biodefense Market is segmented by Type, Application, and region. Based on Type, the market is segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear, Others. Based on Application, the market is segmented into Hospitals and clinics, Ambulatory care centers, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Drivers of the Global Biodefense Market

A major driver of the global biodefense market is the growing awareness of the severe and potentially catastrophic impacts of biological threats. In response, governments, defense agencies, and healthcare organizations around the world are making substantial investments in biodefense measures. These efforts are aimed at addressing and mitigating the risks associated with bioterrorism, pandemics, and other biological emergencies, highlighting the urgent need for enhanced preparedness and response capabilities.

Restraints in the Global Biodefense Market

A significant constraint for the Global Biodefense Market is the substantial financial burden associated with the research and development of biodefense solutions. The creation of effective vaccines, therapeutics, and detection systems demands considerable investment in areas such as research, clinical trials, and regulatory compliance. This high cost, compounded by the intricate nature of biodefense threats, makes it challenging to develop cost-effective solutions and impedes overall market growth. The financial demands and complex challenges associated with biodefense R&D can limit the pace of innovation and market expansion, further restricting progress in this critical field.

Market Trends of the Global Biodefense Market

A significant trend in the global biodefense market is the heightened emphasis on advancing diagnostic technologies. This trend reflects a growing need for rapid and precise detection of biological agents, which is crucial for early intervention and effective response during biodefense incidents. The development of innovative diagnostic tools, including point-of-care testing devices and molecular diagnostics, is central to this focus. These technologies aim to enhance both the speed and accuracy of identifying potential biological threats. By improving surveillance systems and overall preparedness, these advancements are expected to bolster response capabilities in biodefense scenarios.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Landscape
• Patent Analysis
• Pipeline Product Analysis
• PESTEL Analysis

Biodefense Market, By Type

• Market Overview
• Anthrax
• Smallpox
• Botulism
• Radiation/Nuclear
• Others

Biodefense Market, By Application

• Market Overview
• Hospitals and clinics
• Ambulatory care centres
• Others

Biodefense Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• XOMA Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Altimmune Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emergent Biosolutions Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynavax Technologies Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SIGA Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elusys Therapeutics Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ichor Medical Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynport Vaccine Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cleveland Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bavarian Nordic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ology Bioservices
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alnylam Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioCryst Pharmaceuticals Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PharmAthene Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Profectus Biosciences Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoViricides Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takeda Pharmaceutical Company Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Pasteur
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GlaxoSmithKline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments